Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1482 Articles

Chris Lange | Jan 5, 2017 at 11:05 AM EST

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a…

Jon C. Ogg | Dec 31, 2016 at 11:14 AM EST

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the…

Jon C. Ogg | Dec 29, 2016 at 10:30 AM EST

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

The Dow has been within 1% of 20,000 for days now. What if the Dow actually manages to hit 22,000…

Douglas A. McIntyre | Dec 29, 2016 at 7:35 AM EST

5 Companies That Will Kill the Dow’s Move to 20,000

Most of the 30 components of the Dow Jones Industrial Average have risen by double-digit percentages this year. But these…

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Douglas A. McIntyre | Dec 22, 2016 at 6:40 AM EST

5 Stocks That Will Keep the Dow Under 20,000

Dow 20,000 does not need all of the index's components to do well. However, these five could be a big…

Paul Ausick | Dec 21, 2016 at 4:01 PM EST

Merck, Pfizer Weigh on DJIA Wednesday

December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think…

Chris Lange | Dec 19, 2016 at 12:20 PM EST

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key…

Paul Ausick | Dec 12, 2016 at 4:01 PM EST

J&J, Wal-Mart Lift Dow Higher Monday

December 12, 2016: Markets opened mixed Monday as traders position themselves for the FOMC meeting announcement due on Wednesday. An…

Jon C. Ogg | Dec 12, 2016 at 11:10 AM EST

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

At the end of each year, investors look for opportunities and safe harbors to park their money for the year…

Chris Lange | Dec 12, 2016 at 8:44 AM EST

Short Sellers Back Way Off Major Pharma Stocks

The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected…

Paul Ausick | Dec 11, 2016 at 9:18 AM EST

Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow

With three weeks remaining in 2016, just four DJIA stocks are trading down for the year and all but one…

Paul Ausick | Dec 9, 2016 at 4:01 PM EST

Pfizer, Coca-Cola Lead Dow Higher Friday

December 9, 2016: Markets opened higher again Friday with little support from either economic data or corporate earnings. One big…

Jon C. Ogg | Dec 6, 2016 at 11:35 AM EST

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

It turns out that 11 of the 30 Dow Jones Industrial Average stocks have a consensus price target that calls…

Lee Jackson | Dec 1, 2016 at 8:10 AM EST

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for…

1 … 43 44 45 46 47 … 99

Pfizer : PFE

All Pfizer Articles

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Short Interest Rises in Major Pharma

5 Stocks That Will Keep the Dow Under 20,000

Merck, Pfizer Weigh on DJIA Wednesday

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

J&J, Wal-Mart Lift Dow Higher Monday

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

Short Sellers Back Way Off Major Pharma Stocks

Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow

Pfizer, Coca-Cola Lead Dow Higher Friday

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Live Nasdaq Composite: Semiconductor Stumble Tests the Market’s AI Conviction

Zuckerberg Backs Down on AI Tracking After Meta Employee Revolt – But They’ll Still Get the Data They Need

Got $10,000? TSM vs Micron: The Better Buy in 2026

After Reviewing Every Cybersecurity ETF These 3 Capture the Full Stack Most Investors Miss

Medicare's IRMAA Cliff Just Erased Your 2026 Social Security Raise. Here's Why

A 60-Year-Old Couple With $2.8 Million Can Retire by Year-End 2027 If This One Withdrawal Number Holds

Zuckerberg Backs Down on AI Tracking After Meta Employee Revolt – But They’ll Still Get the Data They Need

Got $10,000? TSM vs Micron: The Better Buy in 2026

Pfizer : PFE

All Pfizer Articles

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Beyond DJIA 20,000: What Could Drive the Dow to 22,000 in 2017

5 Companies That Will Kill the Dow’s Move to 20,000

Short Interest Rises in Major Pharma

5 Stocks That Will Keep the Dow Under 20,000

Merck, Pfizer Weigh on DJIA Wednesday

Portola Pharma Wins on Pfizer and Bristol-Myers Loan Agreement

J&J, Wal-Mart Lift Dow Higher Monday

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

Short Sellers Back Way Off Major Pharma Stocks

Just 4 DJIA Stocks Trading Down This Year: Nike, Coke, Pfizer, Disneydow

Pfizer, Coca-Cola Lead Dow Higher Friday

The 11 Most Attractive Dow Stocks for 2017: Is DJIA 22,000 in the Cards?

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Live Nasdaq Composite: Semiconductor Stumble Tests the Market’s AI Conviction

Zuckerberg Backs Down on AI Tracking After Meta Employee Revolt – But They’ll Still Get the Data They Need

Got $10,000? TSM vs Micron: The Better Buy in 2026

After Reviewing Every Cybersecurity ETF These 3 Capture the Full Stack Most Investors Miss

Featured Reads

Medicare's IRMAA Cliff Just Erased Your 2026 Social Security Raise. Here's Why

A 60-Year-Old Couple With $2.8 Million Can Retire by Year-End 2027 If This One Withdrawal Number Holds